Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Txcell (TXCL)

Paris
Currency in EUR
Disclaimer
2.58
0.00(0.00%)
Closed
TXCL Scorecard
Fair Value
Unlock Value
Day's Range
2.582.58
52 wk Range
0.002.58
Bid/Ask
2.38 / 2.58
Prev. Close
2.58
Open
2.58
Day's Range
2.58-2.58
52 wk Range
0-0
Volume
0
Average Vol. (3m)
23,849
1-Year Change
0%
Shares Outstanding
25,450,903
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about TXCL?
Vote to see community's results!
or
  • TxCell: Lonza To Make CAR Tregs
  • TXCL: Robust And Stable Treg Manufacturing

Txcell Company Profile

Sangamo Therapeutics France S.A.S., a biotechnology company, develops cellular immunotherapies based on regulatory T cells Tregs for inflammation, autoimmunity, and transplantation. Its cellular therapy products are composed of Tregs with a chimeric antigen receptor CAR. The company’s product candidates include TX200, a CAR-Treg-based cellular immunotherapy for the prevention of graft rejection in the context of solid organ transplantation. It is also involved in the development of CAR-Treg-based cellular immunotherapies for bullous pemphigoid, a rare potentially fatal autoimmune disease, as well as for the treatment of multiple sclerosis; and Ovasave for refractory Crohn's disease. The company has strategic research and development collaboration agreements with the Lübeck Institute of Experimental Dermatology, University of British Columbia, and Center for Research in Transplantation and Immunology. Sangamo Therapeutics France S.A.S. is headquartered in Valbonne, France. As of October 1, 2018, Sangamo Therapeutics France S.A.S. operates as a subsidiary of Sangamo Therapeutics, Inc.

Industry
-
Sector
-
Employees
45
Market
France
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.